<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00991627</url>
  </required_header>
  <id_info>
    <org_study_id>ANEST-OST-02</org_study_id>
    <nct_id>NCT00991627</nct_id>
  </id_info>
  <brief_title>Different Approaches to Maternal Hypotension During Cesarean Section</brief_title>
  <official_title>Pharmacological or Non-Pharmacological Management of Maternal Hypotension During Elective Cesarean Section Under Subarachnoid Anesthesia: a Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliero-Universitaria di Parma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Parma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare two different therapeutic approaches to blood pressure
      reduction: pharmacological vs. non-pharmacological. The setting is that of patients
      undergoing scheduled Cesarean section under spinal anesthesia and suffering from aorta-caval
      compression syndrome, which causes a sudden drop in blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The supine hypotensive syndrome of pregnancy is induced by compression of the inferior caval
      vein by the enlarged uterus. It occurs in approximately 8% of pregnant women at term. More
      patients may develop an asymptomatic variety of this syndrome in the supine position. The
      hypotensive effect of spinal anesthesia per se may thus be aggravated in a significant number
      of term parturients. A preoperative supine stress test (SST) before elective cesarean section
      under spinal anesthesia has been shown to predict severe systolic hypotension with reasonable
      accuracy.

      Different strategies have been proposed for the management of this complication; they can be
      divided into pharmacological and non-pharmacological ones.

      According to pharmacological strategies, vasoactive drugs are used to treat hypotension
      induced by sympathetic efferent blockade following spinal anesthesia. To this end, α-agonist
      ephedrine is commonly considered the best choice because of its minimal impact on the
      fetoplacental circulation. However, excessive use of ephedrine may be detrimental to neonatal
      well-being because of its vasoconstrictor effect on fetoplacental circulation.

      Non-pharmacological treatments may represent a valuable, safer alternative. According to many
      authors non-pharmacological treatments aimed at removing the cause of aorta-caval compression
      syndrome are to be preferred because more appropriate from an etiopathogenetic point of view.
      The use of a wedge-shaped cushion placed under the right hip is a well-known
      non-pharmacological strategy which allows the uterine left lateral displacement and,
      consequently, the removing of the compression from the inferior vena cava.

      The aim of the present study is to compare, through the evaluation of neonatal well-being,
      the efficacy of these approaches to hypotension after spinal anesthesia for elective
      Caesarean section in parturients affected by aorto-caval compression.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neonatal arterial base excess</measure>
    <time_frame>&lt;5 min from birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal arterial and venous pH, venous base excess</measure>
    <time_frame>&lt;5 min from birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar score</measure>
    <time_frame>1 and 5 minutes from birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal serum levels of cardiac troponin (baseline, immediate postsurgery, 6 and 12 hours after surgery)</measure>
    <time_frame>Baseline and up to 12 h postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of maternal hypotension ( &lt;20% baseline or mean arterial pressure &lt;60 mmHg).</measure>
    <time_frame>q5min from anesthesia to end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of maternal bradycardia (heart rate &lt;30% of baseline or &lt;60 beats per minute)</measure>
    <time_frame>q5min from anesthesia to end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral arterial oxygen saturation: incidence of desaturation (SpO2 &lt;92%) and mean values for each arm.</measure>
    <time_frame>q5min from anesthesia to end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Administered atropine</measure>
    <time_frame>from anesthesia to end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of ephedrine administered (mg)</measure>
    <time_frame>from anesthesia to end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time between induction of anesthesia and skin incision</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time between skin incision and delivery</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Pregnancy</condition>
  <condition>Cesarean Section</condition>
  <condition>Anesthesia,Spinal</condition>
  <condition>Hypotension</condition>
  <arm_group>
    <arm_group_label>Pharmacological</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will receive a basal infusion of ephedrine. Hypotension will be treated for a reduction in systolic blood pressure 20% below baseline values.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Pharmacological</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will undergo uterine lateral displacement through the use of a wedge-shaped cushion placed under their right hip. Hypotension will be treated for a reduction in systolic blood pressure 40% below baseline values.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>10 mg of a 5 mg/ml hyperbaric solution, intrathecally</description>
    <arm_group_label>Pharmacological</arm_group_label>
    <arm_group_label>Non-Pharmacological</arm_group_label>
    <other_name>Marcain</other_name>
    <other_name>Local Anesthetic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>200 µg of a 100 µg/ml solution, intrathecally</description>
    <arm_group_label>Pharmacological</arm_group_label>
    <arm_group_label>Non-Pharmacological</arm_group_label>
    <other_name>Intrathecal morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactated Ringer's solution</intervention_name>
    <description>25 ml/min intravenously</description>
    <arm_group_label>Pharmacological</arm_group_label>
    <arm_group_label>Non-Pharmacological</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ephedrine, continuous infusion</intervention_name>
    <description>37.5 mg/h intravenously</description>
    <arm_group_label>Pharmacological</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ephedrine, bolus</intervention_name>
    <description>6.25 mg IV bolus prn.
Hypotension defined according to study protocol for each arm.</description>
    <arm_group_label>Pharmacological</arm_group_label>
    <arm_group_label>Non-Pharmacological</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atropine</intervention_name>
    <description>0.1 mg/kg iv bolus prn
Bradycardia defined as 50% drop in heart rate from baseline values.</description>
    <arm_group_label>Pharmacological</arm_group_label>
    <arm_group_label>Non-Pharmacological</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing spinal anesthesia for elective Cesarean section

          -  Patients in ASA Physical Status Class I or II

          -  Informed written consent to participation

          -  Positive Supine Stress Test

        Exclusion Criteria:

          -  Any known fetal pathology

          -  Indication to general anesthesia

          -  Known allergy to any of the study drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guido Fanelli, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Anesthesiology and Critical Care Medicine, University of Parma, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Cornini, MD</last_name>
    <role>Study Director</role>
    <affiliation>UO II Anestesia, Rianimazione e Terapia Antalgica, Azienda Ospedaliero-Universitaria di Parma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michele Zasa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Anesthesiology and Critical Care Medicine, University of Parma, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University and Hospital of Parma (Azienda Ospedaliero-Universitaria di Parma)</name>
      <address>
        <city>Parma</city>
        <state>PR</state>
        <zip>43126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Kinsella SM, Lohmann G. Supine hypotensive syndrome. Obstet Gynecol. 1994 May;83(5 Pt 1):774-88. Review.</citation>
    <PMID>8164943</PMID>
  </reference>
  <reference>
    <citation>Cyna AM, Andrew M, Emmett RS, Middleton P, Simmons SW. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD002251. Review.</citation>
    <PMID>17054153</PMID>
  </reference>
  <reference>
    <citation>Kinsella SM, Norris MC. Advance prediction of hypotension at cesarean delivery under spinal anesthesia. Int J Obstet Anesth. 1996 Jan;5(1):3-7.</citation>
    <PMID>15321375</PMID>
  </reference>
  <reference>
    <citation>Helwig JT, Parer JT, Kilpatrick SJ, Laros RK Jr. Umbilical cord blood acid-base state: what is normal? Am J Obstet Gynecol. 1996 Jun;174(6):1807-12; discussion 1812-4.</citation>
    <PMID>8678144</PMID>
  </reference>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2009</study_first_submitted>
  <study_first_submitted_qc>October 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2009</study_first_posted>
  <last_update_submitted>August 26, 2010</last_update_submitted>
  <last_update_submitted_qc>August 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Guido Fanelli</name_title>
    <organization>UO II Anestesia, Rianimazione e Terapia Antalgica, Azienda Ospedaliero-Universitaria di Parma</organization>
  </responsible_party>
  <keyword>Ephedrine</keyword>
  <keyword>Adrenergic Agents</keyword>
  <keyword>Central Nervous System Stimulants</keyword>
  <keyword>Sympathomimetics</keyword>
  <keyword>Vasoconstrictor Agents</keyword>
  <keyword>Bupivacaine</keyword>
  <keyword>Anesthetics, Local</keyword>
  <keyword>Atropine</keyword>
  <keyword>Adjuvants, Anesthesia</keyword>
  <keyword>Anti-Arrhythmia Agents</keyword>
  <keyword>Bronchodilator Agents</keyword>
  <keyword>Muscarinic Antagonists</keyword>
  <keyword>Mydriatics</keyword>
  <keyword>Parasympatholytics</keyword>
  <keyword>Morphine</keyword>
  <keyword>Analgesics, Opioid</keyword>
  <keyword>Narcotics</keyword>
  <keyword>Ringer's Lactate</keyword>
  <keyword>Isotonic Solutions</keyword>
  <keyword>Hypotension</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Signs and Symptoms</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Anesthesia, Obstetrical</keyword>
  <keyword>Inferior Vena Cava</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Ephedrine</mesh_term>
    <mesh_term>Pseudoephedrine</mesh_term>
    <mesh_term>Central Nervous System Stimulants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

